Artificial intelligence can use brain recordings from a single night in a sleep lab to predict a person's risk of developing ...
The FDA has granted Breakthrough Therapy designation to alixorexton for the treatment of narcolepsy type 1 (NT1).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback